Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis

Clinical Science

Volumn 107, Issue 4, 2004, Pages 381-389

  Ribichini, Flavio ^a   Ferrero, Valeria ^a   Matullo, Giuseppe ^b,c   Feola, Mauro ^d   Vado, Antonello ^d   Camilla, Terenzio ^d   Guarrera, Simonetta ^b   Carturan, Sonia ^b   Vassanelli, Corrado ^a   Uslenghi, Eugenio ^d   Piazza, Alberto ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c ISI FOUNDATION   (Italy)

^d S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Angioplasty; Angiotensin converting enzyme (ACE); Polymorphism; Restenosis; Stent

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CONFIDENCE INTERVAL; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTENOSIS; RISK FACTOR; SAMPLING; STENT;

AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; SAMPLE SIZE; STENTS;

EID: 6344226510     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030380     Document Type: Article

References (28)

1. Amant, C., Bauters, C., Bodart, J. C. et al. (1997) D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation 96, 56-60
2. Ribichini, F., Steffenino, G., Dellavalle, A. et al. (1998) Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme. A major risk factor and a marker of risk for coronary stent restenosis. Circulation 97, 147-154
3. Koch, W., Kastrati, A., Mehilli, J., Bottiger, C., von Beckerath, N. and Schomig, A. (2000) Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation 102, 197-202
4. Jorgensen, E., Kelbaek, H., Helqvist, S. et al. (2001) Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors. J. Am. Coll. Cardiol. 38, 1434-1439
5. Ohishi, M., Fuji, K., Minamino, T. et al. (1993) A potent genetic risk factor for restenosis. Nat. Genet. 5, 324-325
6. Zee, R. Y. L., Fernandez-Ortiz, A., Macaya, C., Pintor, E., Lindpaintner, K. and Fernandez-Cruz, A. (2001) ACE D/I polymorphism and incidence of post-PTCA restenosis. A prospective, angiography-based evaluation. Hypertension 37, 851-855
7. Bonnici, F., Keavney, B., Collins, R. and Danesh, J. (2002) Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies. Br. Med. J. 325, 517-520
8. Samani, N. J., Thompson, J. R., O'Toole, L., Channer, K. and Woods, K. L. (1996) A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94, 708-712
9. Agerholm-Larsen, B., Nordestgaard, B. G. and Tybjaerg-Hansen, A. (2000) ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler., Thromb., Vasc. Biol. 20, 484-492
10. Mintz, G. S., Popma, J. J., Hong, M. K. et al. (1996) Intravascular ultrasound to discern device-specific effects and mechanism of restenosis. Am. J. Cardiol. 78, 18-22
11. Rakugi, H., Kim, D. K., Krieger, J. E., Wang, D. S., Dzau, V. J. and Pratt, R. E. (1994) Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J. Clin. Invest. 93, 339-346
12. Powell, J. S., Clozel, J. P., Muller, R. K. M. et al. (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (Washington, D.C.) 245, 186-188
13. Tiret, L., Rigat, B., Visvikis, S. et al. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 51, 197-205
14. Ribichini, F., Matullo, G., Piazza, A., Vado, A. and Uslenghi, E. (2000) Relationship between plasma ACE activity and the proliferative healing process in coronary vessel injury after coronary stenting. Atherosclerosis 152, 261-263
15. Ribichini, F., Wijns, W., Ferrero, V. et al. (2003) Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting. Am. J. Cardiol. 91, 154-158
16. Grines, C. L., Cox, D. A., Stone, G. W et al. (1999) Coronary angioplasty with or without stent implantation for acute myocardial infarction. N. Engl. J. Med. 341, 1949-1956
17. Moreno, P., Murcia, A., Palacios, I. et al. (2000) Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 102, 2180-2184
18. Katsuya, T., Horiuchi, M., Chen, Y. D. et al. (1995) Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler., Thromb., Vasc. Biol. 15, 779-7782
19. Panahloo, A., Andres, C., Mohamed-Ali, V. et al. (1995) The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 92, 3390-3393
20. Ryan, A. S., Nicklas, B. J., Berman, D. M. and Ferrell, R. E. (2001) The insertion/deletion polymorphism of the ACE gene is related to insulin sensitivity in overweight women. Diabetes Care 24, 1646-1652
21. Kastrati, A., Mehilli, J., Dirschinger, J. et al. (2001) Restenosis after coronary placement of various stent types. Am. J. Cardiol. 87, 34-39
22. Ribichini, F. (2001) Current perspective: in-stent restenosis. Ital. Heart J. 2, 728-735
23. Serruys, P. W., de Feyter, P., Macaya, C. et al. (2002) Lescol intervention prevention study investigators. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 287, 3259-3261
24. Steinhubl, S. R., Ellis, S. G., Wolski, K., Lincoff, A. M. and Topol, E. J. (2001) Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. Circulation 103, 1403-1409
25. Marso, S. P., Lincoff, M. A., Ellis, S. G. et al. (1999) Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy. Circulation 100, 2477-2484
26. Walter, D. H., Schachinger, V., Elsner, M. et al. (2001) Statin therapy is associated with reduced restenosis rates after coronary stem implantation in carriers of the P1(A2) allele of the platelet glycoprotein IIIa gene. Eur. Heart J. 22, 587-595
27. Mercado, N., Boersma, E., Wijns, W. et al. (2001) Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J. Am. Coll. Cardiol. 38, 645-652
28. Meurice, T., Bauters, C., Hermant, X. et al. (2001) Effect of ACE inhibitors on angiographic restenosis after coronary stealing (PARIS): a randomized, double-blind, placebo-controlled trial. Lancet 357, 1321-1324